UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 331

Sortiert nach

Fit-for-purpose method development and validation for successful biomarker measurement

Pharmaceutical research, 2006-02, Vol.23 (2), p.312-328

2006

Volltextzugriff (PDF)

Disclosure of analytical information in pharmacokinetic papers

Clinical pharmacology and therapeutics, 1997-04, Vol.61 (4), p.494-494

Weinryb, Ira

1997

Volltextzugriff (PDF)

Chylous Transport of Amiodarone

Chest, 1993-02, Vol.103 (2), p.656-656

1993

Volltextzugriff (PDF)

Bioavailability of amiodarone tablets administered with and without food in healthy subjects

The American journal of cardiology, 2001-02, Vol.87 (4), p.432-435

2001

Volltextzugriff (PDF)

Cyclic AMP as an Intracellular Mediator of Hormone Action: Sutherland's Criteria Revisited

Perspectives in biology and medicine, 1979, Vol.22 (3), p.415-420

Weinryb, Ira

1979

Volltextzugriff (PDF)

Antiallergic activity of tiaramide (RHC 2592-A)

International archives of allergy and applied immunology, 1982, Vol.69 (2), p.159

1982

Volltextzugriff (PDF)

Biochemistry and the Search for Therapeutic Agents

Perspectives in biology and medicine, 1975-01, Vol.18 (4), p.506-512

Weinryb, Ira

1975

Volltextzugriff (PDF)

Effects of Therapeutic Agents on Cyclic AMP Metabolism In Vitro

Journal of pharmaceutical sciences, 1972-10, Vol.61 (10), p.1556-1567

1972

Volltextzugriff (PDF)

Synthesis and central nervous system activity of 2-arylidene-4-aminoalkyl-2H-1,4-benzoxazin-3(4H)-ones and related compounds

Journal of medicinal chemistry, 1977-05, Vol.20 (5), p.729-732

1977

Volltextzugriff (PDF)

RHC 3288 [1-methyl-2(1,3,4-oxadiazol-2(3H)-one-5-yl) benzimidazole] and related compounds: Novel inhibitors of histamine release from rat mast cells and human basophils

Biochemical pharmacology, 1983-11, Vol.32 (22), p.3325-3333

1983

Volltextzugriff (PDF)

Loss of IgE receptors and shedding of a protease during purification of mast cells

International archives of allergy and applied immunology, 1981, Vol.66 Suppl 1, p.78

1981

Volltextzugriff (PDF)

Cyclic nucleotides vs. adenosine analogs as inhibitors of adenylate cyclase activity: nonidentity of sites of action

Experientia, 1975-08, Vol.31 (8), p.892-894

1975

Volltextzugriff (PDF)

Population distribution and effects on drug metabolism of a genetic variant in the 5' promoter region of CYP3A4

Clinical pharmacology and therapeutics, 1999-09, Vol.66 (3), p.288

1999

Volltextzugriff (PDF)

Radioimmunoassay of cyclic AMP without precipitating antibody

Analytical biochemistry, 1972-02, Vol.45 (2), p.659-663

1972

Volltextzugriff (PDF)

A Population Study on Irritable Bowel Syndrome and Mental Health

Scandinavian journal of gastroenterology, 2000, Vol.35 (3), p.264-268

2000

Volltextzugriff (PDF)

A Pharmacokinetic and Pharmacodynamic Study of the Potential Drug Interaction between Tasosartan and Atenolol in Patients with Stage 1 and 2 Essential Hypertension

Journal of clinical pharmacology, 2000-03, Vol.40 (3), p.231-241

2000

Volltextzugriff (PDF)

Population distribution and effects on drug metabolism of a genetic variant in the 5' promotor region of CγP3A4

Clinical pharmacology and therapeutics, 1999, Vol.66 (3), p.288-294

1999

Volltextzugriff (PDF)

Amine-responsive adenylate cyclase activity from brain: comparisons between rat and rhesus monkey and demonstration of dopamine-stimulated adenylate cyclase in monkey neocortex

Psychopharmacology communications, 1976, Vol.2 (1), p.39

1976

Volltextzugriff (PDF)

Comparative structure-activity relationships for dihydropyridines as inhibitors of [3H]-nitrendipine binding vs cyclic nucleotide phosphodiesterases

Research communications in chemical pathology and pharmacology, 1984-08, Vol.45 (2), p.191

1984

Volltextzugriff (PDF)

D80 Tasosartan and atenolol: Interaction in hypertensives

American journal of hypertension, 1997-04, Vol.10 (S2), p.125A-125A

1997

Volltextzugriff (PDF)

D55 Effects of concomitant tasosartan and HCTZ administration in healthy volunteers

American journal of hypertension, 1997-04, Vol.10 (S2), p.118A-118A

1997

Volltextzugriff (PDF)

The low temperature luminescence of complexes of acridine orange with polyelectrolytes

Biochimica et biophysica acta, 1970-01, Vol.209 (2), p.306-319

1970

Volltextzugriff (PDF)

Substituted arylmethyl phenyl ethers. 1. A novel series of 5-lipoxygenase inhibitors and leukotriene antagonists

Journal of medicinal chemistry, 1987-01, Vol.30 (1), p.96-104

1987

Volltextzugriff (PDF)

Effects of celiprolol (REV 5320), a new cardioselective beta-adrenoceptor antagonist, on in vitro adenylate cyclase, alpha- and beta-adrenergic receptor binding and lipolysis

Archives internationales de pharmacodynamie et de thérapie, 1984-11, Vol.272 (1), p.40

1984

Volltextzugriff (PDF)

The Behavior of Horseradish Peroxidase at High Hydrogen Peroxide Concentrations

Biochemistry (Easton), 1966-06, Vol.5 (6), p.2003-2008

Weinryb, Ira

1966

Volltextzugriff (PDF)

1 – 25 von 331

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(255)
Mit Volltextzugriff
(256)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Fit-for-purpose method development and validation for successful biomarker measurement

Disclosure of analytical information in pharmacokinetic papers

Chylous Transport of Amiodarone

Bioavailability of amiodarone tablets administered with and without food in healthy subjects

Cyclic AMP as an Intracellular Mediator of Hormone Action: Sutherland's Criteria Revisited

Antiallergic activity of tiaramide (RHC 2592-A)

Biochemistry and the Search for Therapeutic Agents

Effects of Therapeutic Agents on Cyclic AMP Metabolism In Vitro

Synthesis and central nervous system activity of 2-arylidene-4-aminoalkyl-2H-1,4-benzoxazin-3(4H)-ones and related compounds

RHC 3288 [1-methyl-2(1,3,4-oxadiazol-2(3H)-one-5-yl) benzimidazole] and related compounds: Novel inhibitors of histamine release from rat mast cells and human basophils

Loss of IgE receptors and shedding of a protease during purification of mast cells

Cyclic nucleotides vs. adenosine analogs as inhibitors of adenylate cyclase activity: nonidentity of sites of action

Population distribution and effects on drug metabolism of a genetic variant in the 5' promoter region of CYP3A4

Radioimmunoassay of cyclic AMP without precipitating antibody

A Population Study on Irritable Bowel Syndrome and Mental Health

A Pharmacokinetic and Pharmacodynamic Study of the Potential Drug Interaction between Tasosartan and Atenolol in Patients with Stage 1 and 2 Essential Hypertension

Population distribution and effects on drug metabolism of a genetic variant in the 5' promotor region of CγP3A4

Amine-responsive adenylate cyclase activity from brain: comparisons between rat and rhesus monkey and demonstration of dopamine-stimulated adenylate cyclase in monkey neocortex

Comparative structure-activity relationships for dihydropyridines as inhibitors of [3H]-nitrendipine binding vs cyclic nucleotide phosphodiesterases

D80 Tasosartan and atenolol: Interaction in hypertensives

D55 Effects of concomitant tasosartan and HCTZ administration in healthy volunteers

The low temperature luminescence of complexes of acridine orange with polyelectrolytes

Substituted arylmethyl phenyl ethers. 1. A novel series of 5-lipoxygenase inhibitors and leukotriene antagonists

Effects of celiprolol (REV 5320), a new cardioselective beta-adrenoceptor antagonist, on in vitro adenylate cyclase, alpha- and beta-adrenergic receptor binding and lipolysis

The Behavior of Horseradish Peroxidase at High Hydrogen Peroxide Concentrations

Suchergebnisse filtern